Overview

Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare changes in cholesterol levels in patients with elevated blood cholesterol with administration of lapaquistat acetate, once daily (QD), and fenofibrate.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Fenofibrate